Regeneration Revolution Will Heal Injuries… and Strengthen Your Portfolio!

By Ray BlancoPosted July 26, 2010

As I have written here many times, stem cell therapies hold enormous promise for curing disease and repairing tissue. Stem cell science even has the potential to stop or reverse the aging process — at some point. Let me introduce you to a new company that will also be on the front lines of regenerative medicine...

You Must Be A Subscriber To View This Content.

If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!

Breakthrough Technology Alert

This is the best time to be investing in world-changing technologies, as unprecedented innovations are taking off right now… Breakthrough Technology Alert tirelessly researches these exciting new breakthrough technologies to keep you well informed, outline specific opportunities, and keep you ahead of the game.

Ray Blanco

Ray Blanco is the editor of Technology Profits Confidential as well as Breakthrough Technology Alert, FDA Profit Alert, and Technology Profits Daily. Ray has been with Seven Figure Publishing since 2010. In 2019, his closed positions in Technology Profits Confidential outperformed the S&P500 by 50%.

View More By Ray Blanco

A Little-Known Medical Device Company Begins to Look Much Less Risky

By Stephen PetranekPosted July 14, 2014

Modern American medicine and your aging heart are a Catch-22. As you get older, and your heart has been beating for a long, long time, the valves begin to stretch and weaken. Then they begin to leak. When the mitral valve begins to leak, the heart can’t pump out as much blood as it once did. You find yourself getting weaker. Exercise for more than a few minutes becomes impossible. The only fix at the moment in the United States is open-heart surgery. The Catch-22 is that most people who are old enough to have a failing mitral valve aren’t strong enough to undergo the surgery — at best, only about 20% of those with mitral regurgitation can even contemplate surgery.

The Emerging Capital Report April 2006 Issue: Here’s the Smartest Way to Make Money From the Internet. Buy Now Before the Price Leaps.

By Seven Figure PublishingPosted April 1, 2006

The Internet. It’s yesterday’s news. Or is it? When businesses related to the World Wide Web and e-commerce dominated the investment world in the late 1990s, they seemingly could do no wrong. Startup companies run by children with half-baked business plans were backed with tens of millions of dollars by venture capitalists. When analysts like...

The Emerging Capital Report: Reactionary Delirium: An Insane World Turns Against Markets

By Seven Figure PublishingPosted November 20, 2003

If you're like most Americans, you may feel that the fall of yet another Bolivian president is hardly news.

The Emerging Capital Report March 2007 Issue: From WIred to Wireless, the Revolution Continues

By Seven Figure PublishingPosted March 1, 2007

In the process of converting the world from wired to wireless communications, one little company is in a commanding position to help lead and milk the next disruptive change.

The Emerging Capital Report: Politics Takes Over the Market: Regulation Intensifies While Authorities Ignore the Real Fraud That Holds Down Stock Prices

By Seven Figure PublishingPosted August 15, 2002

One dollar invested in stocks (S&P 500) from year-end 1925 through 2001 grew to be worth $2,279, while the same dollar invested in risk-free U.S. government Treasury bills grew to be worth $17.20.

A Kinder, Gentler Drug for Serious Pain

By Stephen PetranekPosted November 17, 2014

This biotech has spent nearly a decade developing a drug that works like morphine but doesn’t have serious side effects — especially addiction. I have been aware of its slow but persistent progress for a few years, but only initial investors have been able to join the bandwagon, because the company has not been a public company. That changed on the last day of January this year, when the stock was offered at $11 a share. It closed up the first day at $13.87.

Login